Cre8 Enterprise Limited Overview
Cre8 Enterprise is a micro-cap Hong Kong financial printer. It sits at the compliance chokepoint of the Hong Kong capital market, producing and filing the documents that IPO applicants and listed issuers must publish under the HKEX Listing Rules. These include prospectuses, annual and interim reports, circulars and announcements.
The company does not own a printing plant. It is an asset-light project-management and production house. It outsources physical printing and most translation, and keeps typesetting, proofreading, design, quality assurance and the time-critical electronic submission to HKEX in-house.
Revenue was HK$130.9 million (about US$16.8 million) in FY2025. Revenue has swung sharply toward IPO work: IPO printing rose from 29.5% of sales in FY2023 to 48.2% in FY2025. This tracks Hong Kong's record 2025–2026 IPO cycle, during which Cre8 was the sole financial printer for Zijin Gold International's roughly US$3.2 billion listing.
Its legacy annual-report business is in structural decline because of HKEX's paperless reforms. It is now trying to diversify into Japan, AI-enabled translation and digital IR services.
Company's own description (paraphrased from the FY2025 20-F and the August 2026 press-release boilerplate)
The company describes itself as a 24/7 integrated financial printing service provider. It serves companies listed on The Stock Exchange of Hong Kong (HKEX), IPO applicants, and private companies in the finance and capital-markets sector, under the "Cre8" brand.
Its services span:
-
concept creation and artwork design;
-
typesetting and proofreading;
-
translation, mainly between English and Chinese;
-
printing and binding;
-
logistics arrangement;
-
uploading and electronic submission ("e-Submission") of financial reports and compliance documents to the HKEX website;
-
media placements.
It also offers complementary design services (website design, branding and marketing-content creation). Through its "Cre8IR" platform it distributes announcements, circulars, financial reports and industry news feeds. Since April 2026 it also refers to integrated financial printing in Japan through UPPERHAND Japan Limited.
Independent characterization
Cre8 is best understood as a deadline-driven document-production and regulatory-filing service bureau, not a printer in the industrial sense.
The 20-F risk factors state explicitly that the operating subsidiary:
-
does not operate any printing factory;
-
outsources all printing, binding/packaging and delivery of final outputs;
-
outsources substantially all translation work, with its in-house translation team mainly performing quality assurance.
The value it captures comes from four things:
-
Speed and availability: 24/7 shifts during peak reporting windows.
-
Accuracy under regulatory scrutiny: typesetting of bilingual prospectuses.
-
Information security: handling inside information before public release.
-
Physical proximity to HKEX, sponsors and law firms in Central. Its Grade A premises double as meeting and "war-room" facilities for IPO working parties.
Business model and revenue model
| Dimension | Characterization (source: FY2025 20-F) |
|---|---|
| Revenue type | 100% services. There is no product, subscription or licensing revenue line disclosed. |
| Engagement model (IPO) | Project-by-project, tied to the life of each IPO application. Engagements are non-recurring by nature and end on completion or lapse of the application. |
| Engagement model (listed issuers) | Generally one-year terms for periodic compliance documents (annual/interim reports, announcements, circulars), renegotiated on expiry |
| Pricing | Generally cost-plus. There are no price-adjustment clauses. Out-of-pocket expenses are borne first and re-billed. Final bills frequently differ from quotations because page counts, print quantities, extra colour pages, couriers, overtime and urgent work change. |
| Revenue recognition | The FY2025 revenue disaggregation labels Integrated IPO Financial Printing as "transferred at a point in time". The risk factors refer to IPO revenue being "generally recognized based on stage of completion". These descriptions are in tension within the same filing and are noted rather than resolved. |
| Seasonality | Peaks in March, April, August and September, driven by Listing Rules deadlines for results announcements and reports |
| Cost structure (FY2025) | Cost of revenue was HK$76.05M. Staff cost HK$27.72M (36.4%), translation HK$22.72M (29.9%), printing HK$8.42M (11.1%), lease HK$7.77M (10.2%), other HK$9.43M. |
| Value-chain position | Mid-stream integrator between issuers and their advisers (sponsors, lawyers, auditors) and upstream commodity suppliers (printing houses, translators, logistics) and the regulator's filing systems (HKEX e-Submission, HKEXnews) |
Customer types and end-markets
| Customer type | Description | FY2025 revenue share |
|---|---|---|
| IPO applicants (HKEX Main Board and GEM) | Prospectus production, translation, CSRC filing documents, application-proof and PHIP versions | 48.2% (HK$63.16M) |
| Listed companies: annual/interim reports | Typesetting, design and printing of periodic reports; interactive and web annual reports | 26.4% (HK$34.63M) |
| Listed companies: circulars | Shareholder circulars for transactions, AGMs etc. | 9.1% (HK$11.91M) |
| Listed companies and others: other services | Announcements, debt offering circulars, media placements, design, branding, Cre8IR | 16.2% (HK$21.24M) |
Customer count:
-
401 at 31 December 2024
-
408 at 30 June 2025
-
467 at 31 December 2025
-
550 at 30 June 2026 (record)
Source: press release of 26 August 2026. The same release says IPO filing submissions to HKEX handled by Cre8 rose from 11 (as of 30 June 2025) to 64 (as of 30 June 2026).
Concentration: The FY2025 20-F discloses customer concentration only by receivables. One customer represented 12.2% of accounts receivable at 31 December 2025, and a different one represented 12.2% at 31 December 2024. No customer revenue concentration above 10% was surfaced in the reviewed notes.
Strategy
Stated strategy (IPO prospectus and FY2025 20-F; paraphrased themes)
The F-1/A prospectus identified four competitive strengths:
-
An established track record in one-stop integrated financial printing with a strong customer base.
-
Stringent internal controls covering data security and environmental protection.
-
A stable, dedicated workforce led by experienced management.
-
Stable supplier relationships.
The same document set out these growth strategies:
Strategic initiatives, last 24 months
| Date | Initiative | Type | Disclosed targets or metrics |
|---|---|---|---|
| Jul 2025 | Nasdaq IPO (US$6.67M gross including over-allotment) | Capital markets | Proceeds for working capital and growth strategies; no percentage allocation disclosed |
| 10 Sep 2025 | Explore alliances with Japanese financial printers | Geographic expansion | No partners or terms disclosed |
| 18 Sep 2025 | AI-enhanced translation workflow | Technology / cost | Up to 90% cost reduction versus human translation (company claim) |
| 26 Sep 2025 | Sole printer for the Zijin Gold International IPO | Marquee contract | Deal size about US$3.2B |
| 17 Nov 2025 | Accept crypto payments (USDC, USDT, BTC) | Payments / client convenience | — |
| 25 Nov 2025 | Build an AI-enhanced project-management platform | Technology / productivity | — |
| Jan–Feb 2026 | 1-for-12 reverse split to restore Nasdaq compliance | Capital structure | Compliance regained on 2 Mar 2026 |
| Mar–Apr 2026 | Acquisition of Upperhand (Japan) | M&A / geographic expansion | US$0.2M cash; synergy and revenue targets not disclosed |
| Aug 2026 | Capacity build-out to convert a record backlog | Operations | Backlog value not quantified; customers at 550 |
ESG commitments: No formal emissions, diversity or sustainability targets have been disclosed. Internal controls cover "environmental protection" in general terms (F-1/A).
Cost programs: None with stated targets. The AI-translation initiative is implicitly a gross-margin lever. Translation is 29.9% of cost of revenue, and the non-IPO margin is eroding.
Management guidance and medium-term targets
None issued. The company provides no revenue, margin or earnings guidance.
The 26 August 2026 release offers only qualitative confidence based on backlog, plus the CEO's remark (paraphrased) that demand is in place and the task now is to add capacity, deliver and collect. That release explicitly cautions that customer growth may not translate into proportionate revenue and that backlog may not convert on schedule.
Products & Services
Pricing for all services is project-quoted on a cost-plus basis, with add-on price lists for extra items (FY2025 20-F). No public list prices are disclosed for any service line.
Integrated IPO Financial Printing
| Offering | Description and capabilities | Target customer | Year / version | Notes |
|---|---|---|---|---|
| IPO prospectus production | End-to-end typesetting, bilingual (English/Traditional Chinese) translation, proofreading, graphic design, printing and distribution of application proofs, PHIPs and final prospectuses | HKEX Main Board and GEM IPO applicants and their sponsors and lawyers | Since 2006 | Sole printer on the Zijin Gold International IPO (prospectus dated 19 Sep 2025, about US$3.2B raised) |
| CSRC filing support | Preparation and filing of documents with the China Securities Regulatory Commission for PRC-based issuers under the 2023 Trial Administrative Measures | PRC issuers listing in Hong Kong | Cited in the September 2025 release | Grows with A+H and PRC-company listings |
| HKEX e-Submission | Time-slotted uploading and e-submission of IPO and post-listing documents to HKEX systems on behalf of clients | IPO applicants and listed issuers | Ongoing | Information-security sensitive |
| Working-party facilities | Meeting rooms and verification and drafting space at the Central premises | Sponsors, legal counsel, issuers | Ongoing | 20-F stresses proximity to HKEX and advisers |
| Cross-border / Japan IPO support | Support for cross-border IPOs and dual listings with a Japanese presence | Issuers considering Japanese or Hong Kong dual listings | From April 2026 (Upperhand) | Economics not yet disclosed |
Non-IPO Financial Printing
| Offering | Description and capabilities | Target customer | Year / version | Notes |
|---|---|---|---|---|
| Annual and interim reports | Design, typesetting, proofreading, translation, printing and binding of statutory reports; print-on-demand | HKEX-listed companies | Since 2006 | HK$34.63M FY2025, down from HK$53.02M in FY2023 |
| Interactive, web and animated annual reports | Animated PDF (offered since 2009), web-based and HTML5 mobile versions of results summaries | Large-cap issuers focused on IR presentation | 2009 onward | ARC 2025 Interactive Gold award (China Unicom HK 2024 AR) |
| ESG report production | ESG-compliant financial and sustainability documents | Listed issuers subject to HKEX ESG disclosure rules | Not dated | Listed on the company website |
| Shareholder circulars | Transaction, AGM and EGM circulars | Listed issuers | Ongoing | HK$11.91M FY2025, up 48.3% |
| Results announcements and corporate announcements | Typesetting and HKEX upload of price-sensitive announcements at designated time slots | Listed issuers | Ongoing | Within "Others" |
| Debt offering circulars | Offering documents for listed-company bond issues | Listed issuers | Ongoing | Mentioned in the 20-F risk factors |
| Media placements | Placement of paid announcements in newspapers | Listed issuers | Ongoing | Demand reduced by electronic dissemination rules |
| Multi-exchange compliance documents | Documents compliant with HKEX, SGX, LSE and SEC formats | Multi-listed issuers | Not dated | Per the company website meta description |
Complementary and digital services
| Offering | Description | Target customer | Year | Notes |
|---|---|---|---|---|
| Cre8IR platform (www.cre8ir.com) | Website that disseminates announcements, circulars, financial reports and industry news feeds; also hosts IR pages, including Cre8's own | Listed issuers needing IR web presence | — | Monetization not separately disclosed |
| EDS (client portal, eds.cre8ir.com) | Client login portal linked from the corporate site. Functionality is not described in reviewed filings; presumed to be document exchange and review. | Existing clients | — | Not publicly described |
| Website design, branding, marketing content | Creative agency-style services | Listed and private companies | — | Within "Others" revenue |
Technology initiatives (internal, not yet separately monetized)
| Initiative | Description | Announced | Disclosed metrics |
|---|---|---|---|
| AI-enhanced translation workflow | In-house AI translation with a translation memory that reuses previously translated segments; extending to typesetting, proofreading and design | 18 Sep 2025 | Claims up to 90% cost reduction versus traditional human translation; no time metric |
| AI-enhanced project-management platform | Centralized communication, file sharing, status updates, tagging, real-time notifications, dashboards, task lists, timelines and Gantt charts; IPO version control and filing-timeline oversight | 25 Nov 2025 | Headcount and budget not disclosed |
| Cryptocurrency payments | Clients may settle in USDC, USDT or BTC | 17 Nov 2025 | Usage not disclosed; payment processor not named |
Financial Narrative
Coverage: FY2021 financials were never filed. Only the year-end FY2021 cash and equity balances appear as opening balances. FY2022 income statement and cash flow items come from the FY2024 20-F XBRL. The FY2022 balance sheet is partial. FY2023–FY2025 are from the FY2025 20-F.
Placeholder convention: In multi-year tables, cells that cannot be populated are shown as 0 for chart compatibility and flagged in the notes.
Definitions:
- EBITDA = income from operations + depreciation of property and equipment. Operating-lease amortization is inside lease expense under ASC 842 and is not added back.
Income statement
Notes:
-
FY2021 was not filed, so those cells are placeholders.
-
FY2022 selling expenses were not separately extracted. FY2022 G&A of HK$17.66M is from XBRL. FY2022 included HK$2.89M of government subsidies (Employment Support Scheme).
-
USD figures are given only for years the 20-F translates.
Margins and growth (%)
Revenue CAGR, FY2022–FY2025 (3 years): 10.5%. HK$96.96M grew to HK$130.93M. A 5-year CAGR cannot be computed because FY2020–FY2021 revenue is not disclosed.
Per-share data (post 1-for-12 reverse split; HKD)
Notes:
-
The FY2024 20-F reported FY2022 EPS of –HK$0.55 on the pre-consolidation share base (22.5M shares).
-
FY2024 USD EPS of US$0.44 is the restated HKD figure divided by 7.7677. The FY2024 20-F originally showed US$0.04 pre-consolidation.
-
There are no dilutive instruments disclosed.
Balance sheet
Notes:
- FY2021–FY2022 total assets, liabilities and current items are not disclosed in the reviewed filings (placeholders).
FY2022 and FY2023 bank borrowings are derived: - FY2023 = HK$8.87M at end-FY2024 + HK$0.13M repaid in FY2024 = about HK$9.00M.
-
FY2022 = HK$9.00M – HK$9.0M drawn in FY2023 + HK$20.8M repaid in FY2023 = HK$20.80M.
-
Bank borrowings carry a 100% guarantee under the HKMC SME Financing Guarantee Scheme (FY2025 20-F Note R61). Lender, rate and maturity were not captured.
-
Goodwill from Upperhand (April 2026) will appear only in FY2026 accounts. Consideration was US$0.2M, so any goodwill will be immaterial.
Cash flow
Notes:
- FY2023 related-party flows were a net inflow of HK$22.08M: HK$16.46M of advances plus HK$5.62M of repayments received. The negative sign denotes cash received from related parties.
Aggregator cross-check: Benzinga's TTM cash-flow panel (OCF 11.54M, capex –717.34K, FCF 10.82M, financing 30.10M, net change 40.93M) matches the FY2025 HKD figures exactly but labels them as USD. They are HKD, not USD.
Ratios (computed)
Notes on method:
-
FY2023 ROA, asset turnover, DSO and DPO use year-end balances because FY2022 balances are unavailable.
-
FY2023 ROE is not meaningful because average equity was negative (–HK$0.33M).
-
FY2023 ROIC uses the derived FY2022 bank debt.
-
FY2022 net debt/EBITDA uses negative EBITDA and is not meaningful.
Trend commentary
Revenue. Revenue rose from a FY2022 trough of HK$96.96M (COVID-era IPO drought, with Hong Kong IPO proceeds collapsing in 2022) to HK$115.29M in FY2023. It slipped to HK$103.82M in FY2024 as annual-report revenue shrank, then jumped 26.1% to a record HK$130.93M in FY2025.
The FY2025 rebound was entirely IPO-driven: IPO revenue rose HK$30.37M while non-IPO revenue fell HK$3.26M. The inflection point is H2 2025. H1 2025 revenue was only 1.4% above H1 2024 (HK$58.76M vs HK$57.96M), which implies H2 2025 revenue of about HK$72.17M versus about HK$45.86M in H2 2024, a 57% increase.
Gross margin. Gross margin recovered from 23.8% in FY2022 to about 41% from FY2023 and edged up to 41.9% in FY2025. This is purely a mix effect: the 61.7%-margin IPO line displaced the 23.4%-margin non-IPO line. Underneath, non-IPO margins are deteriorating fast, down 8.4 percentage points over two years. Fixed staff and lease costs are being spread over a shrinking annual-report book while translation and printing costs rise.
Operating income — the key FY2025 anomaly. Despite record gross profit, operating income fell 29% to HK$5.86M (4.5% margin, versus 8.0% in FY2024). Three drivers explain it:
-
Selling and marketing employee compensation more than doubled, from HK$8.38M to HK$18.87M. Total S&M rose 70.9% to HK$27.33M, now 20.9% of revenue versus 15.4%. The 20-F categorizes it as employee compensation, which is consistent with deal-linked sales bonuses, expanded sales headcount, or both. The company does not further explain it in reviewed materials.
-
Legal and professional fees tripled, from HK$1.56M to HK$4.59M, reflecting public-company costs post-IPO.
-
G&A employee compensation rose 42% to HK$7.77M.
Partly offsetting these, expected credit-loss provisions fell to HK$0.76M from HK$1.20M (HK$2.91M in FY2023).
H2 2025 swing to a loss. H1 2025 net income was HK$8.03M and full-year net income was HK$5.28M. This implies an H2 2025 net loss of about HK$2.76M on record H2 revenue. Correspondingly, H1 2025 S&M was HK$7.7M, which implies about HK$19.6M in H2 alone. This is the single most important analytical observation in the financials. Higher activity did not translate into profit, which echoes the CEO's August 2026 comment that the company now needs to "build enough capacity to fulfil the customers and collect the money".
Balance sheet transformation. The IPO raised HK$45.13M net. It recapitalized a balance sheet that had negative equity at end-FY2022 and negative working capital of –HK$17.83M at end-FY2023.
At end-FY2025:
-
equity was HK$51.44M;
-
cash was HK$54.71M, about US$7.03M;
-
bank-only net cash was HK$46.63M;
-
the current ratio was 1.57x.
A material part of the IPO proceeds (HK$10.59M) went to repaying balances owed to the ultimate controlling shareholders. Amounts due to related parties fell from HK$11.56M to HK$0.97M.
Cash generation. OCF improved every year from FY2022 (–HK$13.86M → HK$5.48M → HK$6.98M → HK$11.54M). FY2025 OCF was flattered by working-capital inflows from customer prepayments: advances from customers rose HK$5.36M and contract liabilities rose HK$4.76M, which reflects IPO deposits. Capex is negligible at under 0.6% of revenue, so FCF tracks OCF closely.
Receivables. DSO improved markedly from about 94 days (FY2023) to about 58 days (FY2025). The allowance for credit losses keeps climbing in absolute terms (HK$7.02M at end-FY2025, 23.7% of gross receivables of HK$29.61M), and a HK$3.635M collection lawsuit is pending. Collection risk is high relative to the size of the business.
Leases. Operating lease liabilities tripled to HK$20.51M after a new Central lease was recognized (HK$22.93M of initial ROU recognition in FY2025). Undiscounted lease payments are HK$10.50M due in 2026 and HK$9.73M in 2027. A renewal or relocation decision therefore looms around 2027–2028. Rent is a structurally high cost: total lease cost was HK$7.77M in FY2025 within cost of revenue, plus HK$2.63M in G&A.
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansFinancial Detail
Group Entities
| Entity | Jurisdiction | Established | Ownership | Principal activity |
|---|---|---|---|---|
Cre8 Enterprise Limited | BVI | 4 Dec 2023 | Listed parent | Holding company |
Cre8 Incorporation Limited | BVI | 6 Dec 2023 | 100% by parent | Investment holding |
Cre8 (Greater China) Limited | Hong Kong | 16 Sep 2006 | 100% by Cre8 Incorporation | Printing, media placement, translation and related services; this is the operating subsidiary |
Chuangbafang Enterprise Management (Shanghai) Co., Ltd. | PRC | 2021 | 100% by Cre8 Hong Kong | Financial-printing consultation; representative and marketing office; no revenue |
Upperhand Investment Limited | BVI | — | 100% by Cre8 Incorporation (from 1 Apr 2026) | Holding company |
UPPERHAND Japan Limited | Japan | — | 100% by Upperhand | Integrated financial printing in Japan |
“—” = not publicly disclosed.
Revenue by Segment
| Category | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
Integrated IPO Financial Printing revenue (HKD Mn) | 34.04 | 32.79 | 63.16 |
Non-IPO Financial Printing revenue (HKD Mn) | 81.25 | 71.03 | 67.78 |
of which Annual reports (HKD Mn) | 53.02 | 41.61 | 34.63 |
of which Circulars (HKD Mn) | 8.69 | 8.03 | 11.91 |
of which Others (HKD Mn) | 19.53 | 21.39 | 21.24 |
Total revenue (HKD Mn) | 115.29 | 103.82 | 130.93 |
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansRevenue by Segment and Segment Margins & Growth (%)
| Metric | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
IPO cost of revenue (HKD Mn) | 12.83 | 11.07 | 24.16 |
IPO gross profit (HKD Mn) | 21.21 | 21.72 | 39.00 |
IPO gross margin (%) | 62.3 | 66.2 | 61.7 |
Non-IPO cost of revenue (HKD Mn) | 55.44 | 50.36 | 51.89 |
Non-IPO gross profit (HKD Mn) | 25.81 | 20.68 | 15.88 |
Non-IPO gross margin (%) | 31.8 | 29.1 | 23.4 |
Group gross margin (%) | 40.8 | 40.8 | 41.9 |
Segment Margins & Growth (%) and Revenue by Segment (%)
| Metric | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
IPO revenue YoY growth (%) | 0 | -3.7 | 92.6 |
Non-IPO revenue YoY growth (%) | 0 | -12.6 | -4.6 |
Annual reports YoY growth (%) | 0 | -21.5 | -16.8 |
Circulars YoY growth (%) | 0 | -7.6 | 48.3 |
IPO share of revenue (%) | 29.5 | 31.6 | 48.2 |
Non-IPO share of revenue (%) | 70.5 | 68.4 | 51.8 |
IPO share of gross profit (%) | 45.1 | 51.2 | 71.1 |
Revenue by Segment (Half-Yearly)
| Category | H1 2024 | H1 2025 |
|---|---|---|
IPO printing revenue (HKD Mn) | 17.0 | 24.6 |
Non-IPO printing revenue (HKD Mn) | 41.0 | 34.1 |
Total revenue (HKD Mn) | 57.96 | 58.76 |
Income Statement
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Revenue (HKD Mn) | 0 | 96.96 | 115.29 | 103.82 | 130.93 |
Cost of revenue (HKD Mn) | 0 | 73.85 | 68.27 | 61.43 | 76.05 |
Gross profit (HKD Mn) | 0 | 23.11 | 47.01 | 42.39 | 54.88 |
Selling and marketing expenses (HKD Mn) | 0 | 0 | 18.32 | 15.99 | 27.33 |
General and administrative expenses (HKD Mn) | 0 | 17.66 | 19.61 | 18.14 | 21.69 |
Income from operations (HKD Mn) | 0 | -17.43 | 9.07 | 8.26 | 5.86 |
Depreciation, property and equipment (HKD Mn) | 0 | 1.40 | 1.17 | 0.71 | 0.38 |
EBITDA (HKD Mn) | 0 | -16.03 | 10.24 | 8.96 | 6.25 |
Interest expense (HKD Mn) | 0 | 0.77 | 0.12 | 0.32 | 0.25 |
Pre-tax income (HKD Mn) | 0 | -14.94 | 9.28 | 8.53 | 6.91 |
Income tax expense (HKD Mn) | 0 | -2.67 | 1.50 | 2.13 | 1.63 |
Net income (HKD Mn) | 0 | -12.28 | 7.78 | 6.40 | 5.28 |
Net income (USD Mn, convenience translation) | 0 | 0 | 0 | 0.82 | 0.68 |
Margin Analysis (%)
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Revenue growth YoY (%) | 0 | 0 | 18.9 | -9.9 | 26.1 |
Gross margin (%) | 0 | 23.8 | 40.8 | 40.8 | 41.9 |
Operating margin (%) | 0 | -18.0 | 7.9 | 8.0 | 4.5 |
EBITDA margin (%) | 0 | -16.5 | 8.9 | 8.6 | 4.8 |
Pre-tax margin (%) | 0 | -15.4 | 8.1 | 8.2 | 5.3 |
Net margin (%) | 0 | -12.7 | 6.8 | 6.2 | 4.0 |
Effective tax rate (%) | 0 | 17.8 | 16.2 | 25.0 | 23.6 |
Share Count (M) and Per-Share Data
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Weighted average shares, basic and diluted (M) | 0 | 1.875 | 1.875 | 1.875 | 1.936 |
EPS basic (HKD) | 0 | -6.55 | 4.15 | 3.41 | 2.73 |
EPS diluted (HKD) | 0 | -6.55 | 4.15 | 3.41 | 2.73 |
EPS basic (USD) | 0 | 0 | 0 | 0.44 | 0.35 |
Dividends per share (HKD) | 0 | 0 | 0 | 0 | 0 |
Balance Sheet
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Total assets (HKD Mn) | 0 | 0 | 71.43 | 57.05 | 116.02 |
Cash and cash equivalents (HKD Mn) | 20.40 | 0.85 | 14.75 | 13.85 | 54.71 |
Accounts receivable, net (HKD Mn) | 0 | 0 | 29.55 | 18.86 | 22.58 |
Total current assets (HKD Mn) | 0 | 0 | 48.13 | 42.44 | 85.18 |
Right-of-use assets (HKD Mn) | 0 | 0 | 0 | 6.48 | 19.93 |
Bank borrowings, all current (HKD Mn) | 0 | 20.80 | 9.00 | 8.87 | 8.08 |
Long-term bank debt (HKD Mn) | 0 | 0 | 0 | 0 | 0 |
Operating lease liabilities, total (HKD Mn) | 0 | 0 | 0 | 6.48 | 20.51 |
Amounts due to related parties (HKD Mn) | 0 | 0 | 0 | 11.56 | 0.97 |
Total current liabilities (HKD Mn) | 0 | 0 | 65.96 | 43.50 | 54.09 |
Total liabilities (HKD Mn) | 0 | 0 | 67.90 | 47.14 | 64.58 |
Shareholders' equity (HKD Mn) | 8.32 | -4.19 | 3.53 | 9.90 | 51.44 |
Working capital (HKD Mn) | 0 | 0 | -17.83 | -1.06 | 31.09 |
Net debt, bank only (HKD Mn) | 0 | 19.95 | -5.75 | -4.98 | -46.63 |
Net debt including leases (HKD Mn) | 0 | 0 | 0 | 1.50 | -26.12 |
Goodwill and intangibles (HKD Mn) | 0 | 0 | 0 | 0 | 0 |
Cash Flow
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Operating cash flow (HKD Mn) | 0 | -13.86 | 5.48 | 6.98 | 11.54 |
Capital expenditure (HKD Mn) | 0 | 0 | 0.19 | 0.13 | 0.72 |
Free cash flow (HKD Mn) | 0 | 0 | 5.29 | 6.85 | 10.82 |
Net IPO proceeds (HKD Mn) | 0 | 0 | 0 | 0 | 45.13 |
Deferred IPO costs paid (HKD Mn) | 0 | 0 | 1.60 | 2.70 | 3.65 |
Net repayment to related parties (HKD Mn) | 0 | 0 | -22.08 | 4.90 | 10.59 |
Bank loan repayment net of drawdown (HKD Mn) | 0 | 0 | 11.80 | 0.13 | 0.79 |
Dividends paid (HKD Mn) | 0 | 0 | 0 | 0 | 0 |
Share buybacks (HKD Mn) | 0 | 0 | 0 | 0 | 0 |
Net change in cash (HKD Mn) | 0 | -19.47 | 13.97 | -0.88 | 40.93 |
Returns & Leverage Ratios (%) and Financial Ratios (x)
| Ratio | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
ROE, average equity (%) | 0 | 0 | 0 | 95.3 | 17.2 |
ROA, average assets (%) | 0 | 0 | 10.9 | 10.0 | 6.1 |
ROIC, NOPAT / average (equity + bank debt) (%) | 0 | 0 | 52.2 | 39.6 | 11.4 |
Current ratio (x) | 0 | 0 | 0.73 | 0.98 | 1.57 |
Debt/equity, bank only (x) | 0 | 0 | 2.55 | 0.90 | 0.16 |
Debt/equity, including leases (x) | 0 | 0 | 0 | 1.55 | 0.56 |
Net debt/EBITDA, bank only (x) | 0 | -1.24 | -0.56 | -0.56 | -7.46 |
Interest coverage, EBIT/interest (x) | 0 | -22.5 | 73.2 | 26.1 | 23.4 |
Asset turnover (x) | 0 | 0 | 1.61 | 1.62 | 1.51 |
DSO (days) | 0 | 0 | 93.6 | 85.1 | 57.8 |
DPO (days) | 0 | 0 | 59.7 | 58.7 | 46.5 |
Cash conversion cycle (days, no inventory) | 0 | 0 | 33.9 | 26.4 | 11.3 |
Revenue by Region and Region Margins & Growth (%)
| Region | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
Hong Kong revenue (HKD Mn) | 115.29 | 103.82 | 130.93 |
Mainland China revenue (HKD Mn) | 0 | 0 | 0 |
Japan revenue (HKD Mn) | 0 | 0 | 0 |
Hong Kong YoY growth (%) | 0 | -9.9 | 26.1 |
Geographic Revenue
| Category | Hong Kong | Mainland China | Japan | Total |
|---|---|---|---|---|
Integrated IPO Financial Printing | 63.16 | 0 | 0 | 63.16 |
Non-IPO Financial Printing | 67.78 | 0 | 0 | 67.78 |
Total | 130.93 | 0 | 0 | 130.93 |
Share Price & Returns
| Reference point | Price (USD) | Source |
|---|---|---|
IPO price, 22 Jul 2025 (split-adjusted) | 48.00 | Press release ×12 |
52-week high (split-adjusted, aggregator) | 102.18 | Stocktaper; likely early post-IPO trading in 2025 |
Late January 2026, pre-split (≈US$3.97 adjusted) | 0.33 | Yahoo Finance chart (30 Jan 2026) |
26 Aug 2026 close (after the operating update) | 6.81 | Benzinga |
28 Aug 2026 close | 3.91 | Benzinga |
7 Oct 2026 close | 2.65 | FinancialContent historical |
52-week low (aggregators) | 1.68 | Benzinga; Stocktaper |
Performance metric | Value | Note |
Since IPO (to 7 Oct 2026) (%) | -94.5 | US$48.00 → US$2.65 |
1-year (8 Oct 2025 → 8 Oct 2026) (%) | -68 | StockTitan |
Valuation Multiples
| Multiple | Cre8 | DFIN (reference) | Note |
|---|---|---|---|
Market cap (USD Mn) | 5.34 | not computed | — |
P/E, FY2025 EPS US$0.35 (x) | 7.6 | not computed | Benzinga TTM P/E shown at 7.4–19.6x depending on date and price |
P/B, BVPS about US$3.28 (x) | 0.81 | not computed | Benzinga shows 1.82x, computed on the US$3.91 price and its own book value |
P/S (x) | 0.32 | not computed | — |
EV (bank debt only, USD Mn) | -0.65 | — | Negative EV: net cash of about US$6.0M exceeds market cap |
EV including leases (USD Mn) | 1.98 | — | — |
EV/EBITDA including leases (x) | 2.5 | not computed | EBITDA about US$0.80M |
EV/Sales including leases (x) | 0.12 | not computed | — |
Capital Markets
| Item | Status |
|---|---|
Sell-side analyst consensus | None. No published price targets; aggregators show no targets. |
Dividend history | None paid. No dividends in FY2022–FY2025 (cash flow statements). |
Dividend policy | Not formally stated in reviewed sources. Distributions from the Hong Kong subsidiary are not currently restricted under Hong Kong law (20-F). |
Buyback authorizations | None disclosed |
Credit ratings (Moody's / S&P / Fitch) | Not rated |
Debt maturity profile | HK$8.08M of bank borrowings, all classified current (SME Financing Guarantee Scheme, 100% guaranteed). Operating lease payments: HK$10.50M (2026), HK$9.73M (2027), HK$0.90M (2028), HK$0.04M (2029) undiscounted. |
Share Count (M)
| Metric | FY2023 | FY2024 | FY2025 | Feb 2026 |
|---|---|---|---|---|
Class A shares outstanding, as reported at the time (M) | 18.0 | 18.0 | 19.6675 | 1.6390 |
Class B shares outstanding, as reported at the time (M) | 4.5 | 4.5 | 4.5 | 0.375 |
Analyst Conclusions
Management guidance and consensus
Guidance: None issued. The qualitative message from the 26 August 2026 release is that a record backlog underpins confidence for "the coming years", but capacity must be built to fulfil it and to collect receivables.
Consensus: Not available; there is no analyst coverage.
Bull case
-
The IPO supercycle is still in its early-to-middle innings. KPMG reports a record HK$388B raised in nine months of 2026 and over 600 active applicants. Cre8's HKEX submission count rose roughly 6x year on year (11 → 64) and its customers rose 37%. If FY2026 IPO revenue merely grows at half of FY2025's 93% rate, group revenue could exceed FY2025's HK$130.9M comfortably. This is analyst arithmetic, not guidance.
-
The valuation is cash-backed. Bank-only net cash of about US$6.0M (end-FY2025) exceeds the roughly US$5.3M market cap. The stock trades at about 0.8x book and about 7.6x trailing EPS, and the FCF yield is about 26% on FY2025 FCF of about US$1.39M.
-
Mix shift plus AI could re-expand margins. IPO work carries about 62% gross margins and now dominates gross profit (71%). AI translation targets the largest variable cost line (HK$22.7M). Normalizing S&M back toward 15–16% of revenue would restore operating margins toward the 8% of FY2023–FY2024.
Bear case
-
Growth is not converting to profit. FY2025 operating income fell 29% on 26% revenue growth, and H2 2025 was loss-making by about HK$2.76M. If staff costs are structural (capacity build) rather than one-off, margins stay compressed even in a boom.
-
The legacy business is melting, and the cycle will turn. Annual-report revenue is down 35% in two years. The FY2022 precedent shows how fast a downturn bites (a –HK$12.3M loss and negative equity). A Hong Kong IPO slowdown in 2027–2028 would expose a shrunken recurring base.
-
Governance and listing quality. The structure combines:
-
about 88% voting control by a family vehicle in which the operating CEO holds no shares;
-
related-party supply;
-
persistent material weaknesses;
-
a roughly 95% share-price collapse from the IPO;
-
a prior Nasdaq deficiency;
-
a tiny float (about 1.1M public Class A shares) prone to manipulation-like spikes. Minority holders may never realize the cash value per share.
-
Catalysts and monitorables (next 12 months)
| Timing (estimated) | Catalyst / monitorable | What to watch |
|---|---|---|
| Nov–Dec 2026 | H1 2026 unaudited results (6-K) | IPO revenue growth; S&M as % of revenue; whether H2 2025's loss pattern reversed; cash balance |
| Q4 2026 | Hong Kong IPO full-year statistics | Whether HK$500B is reached (KPMG scenario) |
| Ongoing | Nasdaq listing compliance | Price above US$1.00; market value of publicly held shares and stockholders'-equity thresholds |
| FY2026 | Upperhand / Japan contribution | First disclosure of Japan revenue; integration costs; FX |
| FY2026 | AI translation impact | Translation cost as % of revenue (17.3% in FY2025) and non-IPO gross margin |
| FY2026 | Receivables and collections | DSO; credit-loss allowance; outcome of the HK$3.635M suit |
| Apr 2027 | FY2026 Form 20-F | Remediation of material weaknesses; related-party transactions; executive compensation; lease renewal plans |
| 2,027 | Lease maturity for the Central premises | Renewal cost versus relocation risk |
| Any time | Capital actions | Equity raises (dilution risk at about 0.8x book), buybacks or a take-private by the controlling shareholder |
Analyst verdict
Cre8 Enterprise is a genuine, cash-generative niche business wrapped in a deeply flawed public-equity vehicle.
On fundamentals, the company is riding the strongest Hong Kong IPO cycle in its history, and the evidence of participation is concrete:
-
IPO printing revenue nearly doubled in FY2025;
-
it was sole printer on a roughly US$3.2 billion deal;
-
its HKEX submissions rose about six-fold year on year to mid-2026;
-
its customer base hit a record 550.
The asset-light model needs almost no capital. Post-IPO, the balance sheet holds more net cash than the entire market capitalization. A purely quantitative screen would flag CRE as deep value at about 0.8x book, about 7.6x trailing earnings and a negative bank-only enterprise value.
The qualitative picture, however, explains the discount. Profitability is moving the wrong way: record revenue in FY2025 produced lower operating profit, and the second half of 2025 appears to have been loss-making as selling-staff costs ballooned. The recurring annual-report franchise is in structural decline under Hong Kong's paperless reforms, so earnings are increasingly hostage to a notoriously cyclical IPO market.
Governance compounds the problem:
-
dual-class control of about 88% by a family vehicle in which management holds no shares;
-
related-party supply arrangements;
-
three consecutive years of material control weaknesses;
-
a share price down about 95% since listing, accompanied by speculative spikes.
These features make it unlikely that the cash on the balance sheet accrues to minority holders.
Verdict: Speculative / avoid for institutional mandates; trading-only interest for event-driven accounts.
The investment case would improve materially on three things:
-
H1 2026 results showing operating leverage, with S&M normalizing below about 17% of revenue.
-
Evidence that AI translation is lifting non-IPO margins.
-
Concrete capital-return or governance commitments to minority holders.
Absent these, CRE remains a high-volatility proxy on Hong Kong IPO sentiment rather than a compounding business.
APPENDIX A — DATA DISCREPANCIES NOTED
| Item | Source A | Source B | Resolution |
|---|---|---|---|
| FY2024 EPS | HK$0.28 (FY2024 20-F, pre-consolidation) | HK$3.41 (FY2025 20-F, restated for 1:12) | Use restated HK$3.41 |
| FY2025 cash-flow units on Benzinga | Labelled USD (OCF 11.54M etc.) | FY2025 20-F: these are HKD | HKD is correct |
| Chuangbafang incorporation date | 11 May 2021 (FY2025 20-F note) | 5 Nov 2021 (F-1/A) | Likely date-format ambiguity; unresolved |
| IPO revenue recognition | "Transferred at a point in time" (revenue disaggregation note) | "Stage of completion" (risk factors) | Both appear in the FY2025 20-F; unresolved |
| Class B issuance at reorganization | 2,500 Class B shares (Schedule 13D Item 3; F-1/A) | 4,500,000 Class B shares reported | Reconciled by the 1:1,800 split of August 2024 (2,500 × 1,800 = 4,500,000) |
| P/B and P/E on aggregators | Benzinga P/B 1.82x, P/E 7.4–19.6x | Dossier P/B 0.81x, P/E 7.6x | Aggregators use stale prices and inconsistent book values; dossier uses 20-F equity and the 7 Oct 2026 price |
| Employees | 89 (IPO-stage profile) | 91 (current aggregator profile) | Both reported; 20-F Item 6.D not extracted |
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansExecutive Leadership
Board of Directors
| Name | Title | Age / birth year | Tenure | Prior roles / education | Source |
|---|---|---|---|---|---|
CHO Sze Ting | Chairman of the Board, Chief Executive Officer, Director | b. 1974 (about 51–52) | Listed-company role since the 2023–2025 reorganization and IPO; also Managing Director of Cre8 (Greater China) Limited (start date not captured) | Not captured | Yahoo; Simply Wall St; Form 3 (13 Mar 2026); 20-F certifications |
LEE Chi Kam | Chief Financial Officer | b. 1976 | Not captured | Not captured | Yahoo Finance |
LI Yuen Chung | Managing Director and Executive Director | b. 1978 | Not captured | Not captured | Yahoo Finance; Simply Wall St |
HO Armen Ho Tung | Independent Director | Not captured | Simply Wall St reports under 1 year at March 2026. Form 3 event date was 12 Mar 2026, which may reflect the Section 16 filing obligation rather than appointment. | Not captured | Form 3; Simply Wall St |
WONG Ka Chun | Independent Director | Not captured | Under 1 year (Simply Wall St) | Not captured | Simply Wall St |
KAM Lo Chanii | Independent Director | Not captured | Under 1 year (Simply Wall St) | Not captured | Simply Wall St |
Directors' Remuneration
| Item | Detail |
|---|---|
Source | Form 20-F Item 6.B. Foreign private issuers do not file a DEF 14A proxy. |
Aggregate and individual compensation | Aggregators (Yahoo, Simply Wall St) show no compensation data. |
Equity awards | No share incentive plan or share-based compensation expense is evident in the FY2025 income statement; diluted EPS equals basic EPS. |
Clawback | A pay-versus-performance and clawback-related disclosure page exists in XBRL (R27). |
Major Shareholders
| Holder | Class A | Class B | % Class A | % voting power | Source |
|---|---|---|---|---|---|
Cre8 Investments Limited (BVI); reporting person Seng Jin LEE | 6,435,000 pre-split (about 536,250 post-split) | 4,500,000 pre-split (375,000 post-split) | 32.72% | about 87.93% | Schedule 13D (27 Aug 2025) |
Founding pre-IPO holders (14 holders of record, each under 5% per F-1/A) | Not individually disclosed | — | under 5% each | — | F-1/A |
Public float (IPO investors, 1,667,500 shares pre-split including over-allotment) | about 138,958 post-split | — | about 8.5% | — | Derived |
Governance Detail
| Related-party transaction | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
Translation costs paid to LingXpert (HKD Mn) | 4.27 | 3.26 | 3.85 |
Film cost to Green IPO Limited (HKD Mn) | 0.20 | 0.20 | 0 |
Administrative service fee income from related parties (HKD Mn) | 0.37 | 0.39 | 0.18 |
Amounts due to ultimate controlling shareholders, year-end (HKD Mn) | 0 | 11.56 | 0.97 |
Competitive Landscape
Key Competitors
| # | Competitor | Segment overlap | Revenue (latest available) | Positioning versus Cre8 |
|---|---|---|---|---|
| 1 | Donnelley Financial Solutions (DFIN, NYSE) | IPO and capital-markets documents, compliance software, Asia-Pacific capital markets | US$767.0M FY2025 net sales; software 46.7% of sales; adjusted EBITDA margin 31.3% (DFIN FY2025 results release) | Global leader with SaaS (ActiveDisclosure, Venue). Far larger scale; competes for large cross-border deals. |
| 2 | Toppan Merrill (Toppan Group) | Hong Kong and Asia IPO prospectuses, financial reports | Not separately disclosed (part of Toppan Holdings) | Long-established Hong Kong presence; strong with international sponsors |
| 3 | Equity Financial Press (Hong Kong) | IPOs, annual reports, circulars | Private; not disclosed | Major local independent; direct head-to-head competitor |
| 4 | Edition Financial Publishing / Edition Financial Press (Hong Kong) | IPO and compliance documents | Private; not disclosed | Local competitor |
| 5 | iOne Financial Press / iOne Holdings (HKEX-listed) | Financial printing, translation, media | — | Listed local peer; similar service scope |
| 6 | Wonderful Sky Financial Group (HKEX: 1260) | IR, financial PR, design and production of reports | — | Overlaps in IR services and annual-report design |
| 7 | Takara & Company (TSE: 7921; formerly Takara Printing) | Japanese disclosure and IPO documents | — | Dominant Japan incumbent; relevant to Upperhand |
| 8 | Pronexus (TSE: 7893) | Japanese disclosure documents and IPO support | — | Japan's other dominant incumbent |
| 9 | Workiva (WK, NYSE) and other disclosure-software platforms | Self-service report authoring and XBRL tagging | — | Indirect threat: disintermediates typesetting for listed issuers |
| 10 | In-house issuer teams and law-firm document centres | Announcements and simple circulars | — | Substitution threat for low-complexity work |
Peer Comparison FY2025
| Metric | Cre8 (FY2025) | DFIN (FY2025) |
|---|---|---|
Revenue (USD Mn) | 16.82 | 767.0 |
Revenue growth YoY (%) | 26.1 | -1.9 |
Gross margin (%) | 41.9 | 55.9 (GAAP) |
EBITDA margin (%) | 4.8 (reported basis) | 31.3 (adjusted) |
Net margin (%) | 4.0 | 4.2 (includes US$82.8M pension settlement charge) |
R&D / technology intensity | — | software 46.7% of sales |
“—” = not publicly disclosed.
Recent Developments
*Not yet observed: H1 2026 unaudited financial results. H1 2025 results were filed on 1 December 2025, so H1 2026 results could follow on a similar timetable around November–December 2026.
Hiring is implied by the staff-cost increases and the programming-team expansion.



